# A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

> **NCT01671787** · PHASE1 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 51 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** GS-7340
- **DRUG:** Tenofovir disoproxil fumarate

## Key facts

- **NCT ID:** NCT01671787
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01671787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01671787, "A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01671787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*